Skip to the page

Data / Form D filings / Precision Neuroscience Corp

Precision Neuroscience Corp: Form D filings

Precision Neuroscience Corp, a health care company in New York, NY, filed 6 Form D notices with the SEC between 2021 and 2026. The latest, on September 28, 2026, reports $250 million sold of an offering with no set size to 46 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
54 W 21st St. Suite 301, New York, NY, 10010
Phone
(646) 771-5881
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1858288

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 28, 2026New noticeIndefinite$249,999,98446Sep 11, 2026sec.gov
Oct 17, 2024New notice$150,000,000$93,118,915$56,881,08521Oct 2, 2024sec.gov
Apr 2, 2024New notice$45,000,000$27,500,000$17,500,0005Mar 26, 2024sec.gov
Feb 1, 2023Amendment$42,000,000$41,150,023$849,97720Dec 5, 2022sec.gov
Dec 19, 2022New notice$45,000,000$34,300,018$10,699,98215Dec 5, 2022sec.gov
Apr 28, 2021New notice$12,000,000$10,500,000$1,500,0002Apr 16, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael MagerExecutive Officer, DirectorChief Executive Officer
Konstantinos AlatarisExecutive Officer, DirectorPresident
Craig MermelExecutive Officer, DirectorChief AI and Data Officer
Benjamin RapoportExecutive Officer, DirectorChief Science Officer
Ravi MehtaDirector
Howard MorganDirector
Michael KaswanExecutive OfficerChief Financial Officer
Michael GollerDirector
Stephen BiggarDirector

Other health care companies in New York that filed recently

Every Form D from the week of Sep 28, 2026 · All recent filings in New York · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Precision Neuroscience Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.